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In this issue of the Journal, Nallamothu et al. (1) provide an
important addition to the extensive literature on the relation
between volume and outcome in coronary artery bypass
grafting (CABG). They use clinical and administrative data
from 56 U.S. hospitals with CABG patients in 1997,
assessing in-hospital mortality among patients in 25 low-
volume and 31 high-volume CABG hospitals. Like previ-
ous investigators, they find that mortality rates are signifi-
cantly higher in low-volume facilities. More importantly,
they find that these differential outcomes are most clear for
patients with moderate to high predicted probabilities of
in-hospital death, and that there is no noticeable benefit to
minimal- and low-risk patients of being in a high-volume
facility. This leads the researchers to argue for a targeted
strategy of regionalization that focuses on the higher-risk
patients.
See page 1923
My comments deal with three aspects of the study by
Nallamothu et al. (1): 1) its underlying concept, 2) the
empirical application of the concept, and 3) its policy
implications. In brief, the underlying concept is an impor-
tant step forward; the empirical implementation may suffer
from some weaknesses, but despite this, the policy implica-
tions are worthy of serious discussion. That is, their study
can help inform even better empirical work and more
nuanced policy recommendations.
THE UNDERLYING CONCEPT
The investigators recognize that not all patients who are to
undergo CABG are the same, that various patients may
benefit differentially from being operated on in different
settings and that policies to alter the “natural referral
patterns” for CABG should take these differences into
account. They focus their attention on patients for whom
the CABG was not done emergently or was combined with
other procedures, and who did not have coronary angio-
plasty during the same admission. Thus, the patients in
their analysis are those for whom there is a clear “decision-
making opportunity” as to where they should have their
CABG.
Few of the earlier studies of the volume-outcome rela-
tionship made this distinction, although it is clearly relevant
from a clinical perspective. For example, the patient with an
acute myocardial infarction (AMI) who is brought into a
hospital and who then needs emergency revascularization
may be in a very different category of risk (and potential
benefit from regionalization) than patients with elective (or
at least schedulable) admissions. Thus, the separation of
CABG patients into various subgroups on an a priori basis
makes both clinical and policy sense.
THE EMPIRICAL APPLICATION
Nallamothu et al. (1) estimate a logistic risk model to
predict in-hospital death among all the nonemergent cases.
Not surprisingly, age and all patient refined-diagnosis re-
lated group (APR-DRG) severity category are the two most
significant variables. The odds ratio for the APR-DRG
“extreme” category is 80.5, which is so high as to suggest
that the factors leading a patient to be in this category are
not preexisting comorbidities, but rather complications.
This is not surprising; the APR-DRG categories were
originally designed to capture costs, rather than mortality
risks (2,3). Thus, the risk model may actually overcompen-
sate for true risk differences among hospitals.
The risk model is then used to categorize patients into
various groups, ranging from minimal risk (0.5% chance
of in-hospital death) to moderate (2% to 5%), high (5% to
20%), and severe (20%) risk of death. Splitting hospitals
in terms of those with200 cases of nonemergency isolated
CABG versus those with 200 or more such cases, the
investigators (1) find that death rates are significantly higher
in low-volume hospitals for moderate- and high-risk pa-
tients but not severe-risk patients. Although there is risk
stratification in this approach, there is not full risk adjust-
ment. That is, the researchers test for whether a difference
exists in the number of deaths between low- and high-
volume hospitals within a risk category, but not whether
there are more or less than the expected number of deaths.
This is problematic primarily for the top risk category, in
which risk may be between 20% and 100%. This is also the
category with the most potential problems arising from
using APR-DRG categories rather than building a risk
model based on diagnoses that are fairly certain not to be
complications. Thus, the lack of significant volume-
outcome effect for the highest-risk cases may be an artifact.
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POLICY IMPLICATIONS
Nallamothu et al. (1) build upon their estimated empirical
relationship to examine the implications of various region-
alization policies. They examine several volume thresholds
(100, 200 and 300 schedulable CABGs per year) and the
transfer of moderate risk and above, low risk and above, and
all patients from institutions below the threshold. The
concerns raised above about the empirical results are not
likely to alter significantly the potential policy implications
of such analyses. The problematic aspects of the risk
adjustment that have been pointed out are likely, if cor-
rected, to result in somewhat better outcomes among the
higher-volume institutions and thus increase the observed
differences.
Roughly half of all the patients are in the lowest risk
category where there is no mortality benefit to their being
treated in high-volume hospitals. Likewise, there is essen-
tially no benefit for the roughly one-third of patients with
estimated risk of 0.5% to 2.0%. Thus, Nallamothu et al. (1)
argue for a transfer policy targeted at patients with moderate
or higher risk. This makes sense, but the real question is
how to design such a policy.
The data presented in Table 3 of the Nallamothu et al.
(1) study incorporate an interesting but not highlighted
finding. As can be seen in Table 1 derived from their figures,
9.0% of the “elective” patients in low-volume facilities were
high- or severe-risk cases, in contrast to only 6.3% of the
cases in high-volume facilities. This is despite the fact that
these are the cases for whom the high-volume settings have
the greatest advantage. As in the study by Showstack et al.
(4), it appears that the low-volume hospitals “specialize” in
the most difficult cases in which their patients fare the
worst. Whereas that study contrasted emergent and non-
emergent cases, Nallamothu et al. (1) focus only on the
nonemergent cases.
A plausible explanation for this troublesome finding is
that the referral/transfer system works only partially. That
is, the apparent specialization in emergency cases by low-
volume hospitals may be a reflection that most nonemergent
cases are routinely sent to higher-volume and better-
outcome settings, even if this confers little advantage for the
low-risk cases. This leaves the low-volume facilities with a
disproportionate share of the emergency cases. What might
explain a similar phenomenon among the nonemergent
cases? One possible explanation is that, while physicians
who usually practice in the low-volume facilities in major
urban areas refer their high-risk elective cases to higher-
volume hospitals in those areas, physicians in rural settings
and urban areas with only a single CABG-capable facility
do not make such referrals. This may well be rational, and
may even be good patient care. Nallamothu et al.’s (1) Table
3 indicates that the number needed to treat to avoid a death
is 53 or more, with the exception of a referral strategy
targeting patients of moderate risk and above and hospitals
with 200 or fewer CABG patients. One would need to
know whether referral away from one’s usual set of health
care providers—and possibly one’s family—has a substantial
impact on mortality. Furthermore, it is not just the mortal-
ity effect on the patients who are referred, but the possibility
that some patients will not undergo the elective CABG if it
requires a referral outside of the usual provider network.
This may or may not frequently, or ever, be the case, but it
needs to be explored in developing policy recommendations.
More importantly, it is not appropriate to focus a policy
analysis on outcomes only among nonemergent cases. Nal-
lamothu et al. (1) base their volume estimates on just the
nonemergent cases, but it is likely that the experience gained
with emergency CABG patients will be important in
treating the nonemergent ones. Experience with the sched-
uled cases may also affect the outcomes of the emergency
cases that may not be so readily transferred. It is possible
that the mortality savings attributable to the referral or
transfer of high-risk elective cases away from low-volume
settings may be more than offset by the increased mortality
among the nonelective cases treated in those hospitals.
The proposed transfer of high-risk elective cases, how-
ever, is not the only policy option that should be examined.
Another is the closure of (or refusal to open) low-volume
facilities in urban areas served by facilities having better
outcomes. Open-heart surgery facilities are used for various
types of patients including the elective or scheduled CABG
patient, the patient requiring scheduled but complicated
procedures, the patient undergoing a scheduled angioplasty
who then needs emergency CABG, and the patient brought
to the hospital for an AMI who may then need emergency
or urgent revascularization. Nallamothu et al. (1) focus on
the first type and provide evidence for a policy of selective
regionalization. In rural areas, however, it may well be
better, especially for the emergency cases, to have a low-
volume facility than none at all. But substantial research is
needed to examine whether urban patients in general are
better or worse off: 1) in geographic areas with only
high-volume or good-quality facilities; 2) in areas with a
range of facilities and in which there is a policy of selective
referral for high-risk elective cases (the suggestion of Nal-
lamothu et al. [1]); or 3) in areas with a range of facilities
and in which there is no policy of selective referral. Focusing
attention on only one segment of the patient population
Table 1. Distribution of Cases by Estimated Risk Level in
Hospitals With 200 and 200 Elective CABG Cases
Per Year
Estimated Risk of
In-Hospital Mortality
<200 Cases
per Year (%)
>200 Cases
per Year (%)
Minimal-risk (0.5%) 46.6 52.5
Low-risk (0.5%–2%) 35.1 31.8
Moderate-risk (2%–5%) 9.2 9.3
High-risk (5%–20%) 4.6 3.1
Severe-risk (20%) 4.4 3.2
Adapted from Nallamothu et al. (1), Table 3.
CABG  coronary artery bypass grafting.
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that may use facilities for open-heart surgery runs the risk of
harming those who are not being included in the study.
It is also important to move beyond a simple focus on
patient volume. There may be some low-volume facilities
that provide excellent care for all their patients. This may be
the case if the staff is well organized and practices in
multiple facilities—after all, it is not the bricks and mortar
that achieve the better outcomes. Nevertheless, one cannot
use the observation of a low mortality rate in a low-volume
facility to claim that quality is high, because the number of
cases is usually too small to determine whether even an
absence of deaths is less better than what might be expected
given the case mix (5). Contrariwise, high volume does not
guarantee good quality. Volume does, however, make it
easier to measure statistically the risk-adjusted outcomes for
patients at high-volume facilities.
Given that volume per se does little more than assure
reasonable confidence intervals around statistical estimates,
volume-based policies for excluding or closing facilities are
inferior to policies based on the routine reporting of
risk-adjusted outcomes and policies to encourage the refer-
ral of patients toward facilities with better than expected
outcomes and away from those with worse than expected
outcomes. However, selective referrals—especially among
only the nonemergent cases—may not be enough, and
consistently poor outcomes may warrant the closing of a
facility. To the extent that such policies will differentially
target for referral patients with different risk levels, the
benefits of selective referral for one “class” of patients have
to be weighed against the impact of such policies on the
other “classes” of patients. This is not an easy decision to
make because it requires the development of policies that
may yield less expected benefit for some patients in order to
achieve even greater benefit for others. Such, however, is the
problem when we move from a focus on clinical policies
aimed at the individual patient to health policies aimed at
the population of patients. The study by Nallamothu et al.
(1) appropriately forces us to make this transition, but we
need an even broader empirical analysis before being able to
make such policy decisions.
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